Harold Wolf - Publications

Affiliations: 
Pharmacology and Toxicology University of Utah, Salt Lake City, UT 

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 White HS, Franklin MR, Kupferberg HJ, Schmutz M, Stables JP, Wolf HH. The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models. Epilepsia. 49: 1213-20. PMID 18325020 DOI: 10.1111/J.1528-1167.2008.01552.X  0.601
2001 Barton ME, Klein BD, Wolf HH, White HS. Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Research. 47: 217-27. PMID 11738929 DOI: 10.1016/S0920-1211(01)00302-3  0.581
2000 Lian H, Steiner SS, Sofia RD, Woodhead JH, Wolf HH, White HS, Shen GS, Rhodes CA, McCabe RT. A self-complementary, self-assembling microsphere system: application for intravenous delivery of the antiepileptic and neuroprotectant compound felbamate. Journal of Pharmaceutical Sciences. 89: 867-75. PMID 10861587 DOI: 10.1002/1520-6017(200007)89:7<867::Aid-Jps3>3.0.Co;2-S  0.484
2000 White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia. 41: S17-20. PMID 10768294  0.324
1999 Salvati P, Maj R, Caccia C, Cervini MA, Fornaretto MG, Lamberti E, Pevarello P, Skeen GA, White HS, Wolf HH, Faravelli L, Mazzanti M, Mancinelli E, Varasi M, Fariello RG. Biochemical and electrophysiological studies on the mechanism of action of PNU-151774E, a novel antiepileptic compound. The Journal of Pharmacology and Experimental Therapeutics. 288: 1151-9. PMID 10027853  0.413
1998 Fariello RG, McArthur RA, Bonsignori A, Cervini MA, Maj R, Marrari P, Pevarello P, Wolf HH, Woodhead JW, White HS, Varasi M, Salvati P, Post C. Preclinical evaluation of PNU-151774E as a novel anticonvulsant. The Journal of Pharmacology and Experimental Therapeutics. 285: 397-403. PMID 9580576  0.537
1998 White HS, Wolf HH, Woodhead JH, Kupferberg HJ. The National Institutes of Health Anticonvulsant Drug Development Program: screening for efficacy. Advances in Neurology. 76: 29-39. PMID 9408461  0.423
1997 White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Research. 28: 167-79. PMID 9332882 DOI: 10.1016/S0920-1211(97)00045-4  0.545
1997 Rostock A, Tober C, Rundfeldt C, Bartsch R, Unverferth K, Engel J, Wolf HH, White HS. AWD 140-190: a new anticonvulsant with a very good margin of safety. Epilepsy Research. 28: 17-28. PMID 9255596 DOI: 10.1016/S0920-1211(97)00023-5  0.529
1997 Carson JR, Carmosin RJ, Pitis PM, Vaught JL, Almond HR, Stables JP, Wolf HH, Swinyard EA, White HS. Aroyl(aminoacyl)pyrroles, a new class of anticonvulsant agents. Journal of Medicinal Chemistry. 40: 1578-84. PMID 9171868 DOI: 10.1021/jm9606655  0.461
1997 Kehne JH, Kane JM, Chaney SF, Hurst G, McCloskey TC, Petty MA, Senyah Y, Wolf HH, Zobrist R, White HS. Preclinical characterization of MDL 27,192 as a potential broad spectrum anticonvulsant agent with neuroprotective properties. Epilepsy Research. 27: 41-54. PMID 9169290 DOI: 10.1016/S0920-1211(96)01020-0  0.613
1997 Carter RB, Wood PL, Wieland S, Hawkinson JE, Belelli D, Lambert JJ, White HS, Wolf HH, Mirsadeghi S, Tahir SH, Bolger MB, Lan NC, Gee KW. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor. The Journal of Pharmacology and Experimental Therapeutics. 280: 1284-95. PMID 9067315  0.529
1996 Rostock A, Tober C, Rundfeldt C, Bartsch R, Engel J, Polymeropoulos EE, Kutscher B, Löscher W, Hönack D, White HS, Wolf HH. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Research. 23: 211-23. PMID 8739124 DOI: 10.1016/0920-1211(95)00101-8  0.59
1995 Palmer GC, Stagnitto ML, Garske GE, Napier JJ, Harris EW, Kaiser FC, Griffith RC, Woodhead JH, White HS, Wolf HH. Anticonvulsant efficacy/safety properties of 2-amino-N-(1,2-diphenylethyl)acetamide hydrochloride. The Journal of Pharmacology and Experimental Therapeutics. 273: 1023-31. PMID 7791072  0.443
1995 White HS, Harmsworth WL, Sofia RD, Wolf HH. Felbamate modulates the strychnine-insensitive glycine receptor. Epilepsy Research. 20: 41-8. PMID 7713059 DOI: 10.1016/0920-1211(94)00066-6  0.452
1995 White HS, Johnson M, Wolf HH, Kupferberg HJ. The early identification of anticonvulsant activity: role of the maximal electroshock and subcutaneous pentylenetetrazol seizure models. Italian Journal of Neurological Sciences. 16: 73-7. PMID 7642355  0.53
1993 Swinyard EA, Wolf HH, White HS, Skeen GA, Stark LG, Albertson T, Pong SF, Drust EG. Characterization of the anticonvulsant properties of F-721. Epilepsy Research. 15: 35-45. PMID 8391982  0.555
1993 White HS, Hunt J, Wolf HH, Swinyard EA, Falch E, Krogsgaard-Larsen P, Schousboe A. Anticonvulsant activity of the gamma-aminobutyric acid uptake inhibitor N-4,4-diphenyl-3-butenyl-4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridin-3-ol . European Journal of Pharmacology. 236: 147-9. PMID 8319739 DOI: 10.1016/0014-2999(93)90238-D  0.53
1992 White HS, Wolf HH, Swinyard EA, Skeen GA, Sofia RD. A neuropharmacological evaluation of felbamate as a novel anticonvulsant. Epilepsia. 33: 564-72. PMID 1592038 DOI: 10.1111/J.1528-1157.1992.Tb01711.X  0.526
1991 Swinyard EA, White HS, Wolf HH, Bondinell WE. Anticonvulsant profiles of the potent and orally active GABA uptake inhibitors SK&F 89976-A and SK&F 100330-A and four prototype antiepileptic drugs in mice and rats. Epilepsia. 32: 569-77. PMID 1831122  0.506
1986 Chweh AY, Swinyard EA, Wolf HH. Involvement of a GABAergic mechanism in the pharmacologic action of phenytoin. Pharmacology, Biochemistry, and Behavior. 24: 1301-4. PMID 3725833 DOI: 10.1016/0091-3057(86)90188-7  0.305
1985 Chweh AY, Swinyard EA, Wolf HH. Benzodiazepine receptors are not involved in the neurotoxicity and anti-electroshock activity of phenytoin in mice. Neuroscience Letters. 57: 279-82. PMID 2993970 DOI: 10.1016/0304-3940(85)90505-1  0.474
1970 Yeoh PN, Wolf HH. Pharmacological evaluation of seizures induced by electrical stimulation of the hippocampus. Journal of Pharmaceutical Sciences. 59: 950-4. PMID 4393319 DOI: 10.1002/jps.2600590706  0.435
1968 Yeoh PN, Wolf HH. Effects of some adrenergic agents on low frequency electroshock seizures. Journal of Pharmaceutical Sciences. 57: 340-2. PMID 4384437 DOI: 10.1002/jps.2600570227  0.4
Show low-probability matches.